CSIMarket


Integrated Biopharma Inc  (INBP)
Other Ticker:  
 

Integrated Biopharma Inc's Leverage Ratio

INBP's quarterly Leverage Ratio and Total Liabilities, Equity growth




INBP Leverage Ratio (Sep 30 2021)
I. Quarter
(Jun 30 2021)
IV. Quarter
(Mar 31 2021)
III. Quarter
(Dec 31 2020)
II. Quarter
(Sep 30 2020)
I. Quarter
Y / Y Equity Change 109.26 % 136.26 % 135.26 % 164.03 % 220.54 %
Y / Y Total Liabilities Change -46.07 % -34.19 % -0.72 % 0.32 % 0.53 %
Leverage Ratio MRQ 0.63 0.77 1.68 2 2.46
Overall Ranking # # # # #
Seq. Equity Change 3.89 % 47.03 % 15.61 % 18.51 % 17.29 %
Seq. Total Liabilities Change -14.96 % -32.21 % -2.66 % -3.91 % 3.77 %



Leverage Ratio first quarter 2021 Comment
Due to repayements of liabilities of -14.96% Integrated Biopharma Inc improved Leverage Ratio in first quarter 2021 to 0.63, a new company low.

Within Biotechnology & Pharmaceuticals industry in the first quarter 2021, 114 other companies have achieved lower Leverage Ratio than Integrated Biopharma Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are INBP Customers?
Leverage Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 115
Healthcare Sector # 459
Overall Market # 1041


Leverage Ratio Statistics
High Average Low
100.15 15.34 0.63
(Sep 30 2018)   (Sep 30 2021)




Financial Statements
Integrated Biopharma Inc's Equity $ 15 Millions Visit INBP's Balance sheet
Integrated Biopharma Inc's Total Liabilities $ 9 Millions Visit INBP's Balance sheet
Source of INBP's Sales Visit INBP's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingSep 30 2021, within Biotechnology & Pharmaceuticals Industry Leverage RatioSep 30 2021 MRQ Total LiabilitiesSep 30 2021 MRQ Equity
Infinity Pharmaceuticals Inc   1.62 $ 51.925  Millions$ 32.144  Millions
Iteos Therapeutics Inc   1.48 $ 550.340  Millions$ 372.039  Millions
Nanostring Technologies Inc   1.48 $ 294.265  Millions$ 199.119  Millions
Establishment Labs Holdings Inc   1.38 $ 84.832  Millions$ 61.560  Millions
Wave Life Sciences Ltd   1.36 $ 40.528  Millions$ 29.901  Millions
Cure Pharmaceutical Holding Corp   1.34 $ 24.944  Millions$ 18.585  Millions
Gossamer Bio Inc   1.28 $ 217.229  Millions$ 169.809  Millions
Adma Biologics Inc   1.25 $ 128.300  Millions$ 102.780  Millions
Biogen Inc   1.23 $ 13,376.800  Millions$ 10,881.700  Millions
Phathom Pharmaceuticals Inc   1.19 $ 123.616  Millions$ 103.481  Millions
Unity Biotechnology Inc   1.18 $ 67.954  Millions$ 57.737  Millions
Royalty Pharma Plc  1.14 $ 11,829.288  Millions$ 10,386.634  Millions
Cv Sciences Inc   1.10 $ 12.311  Millions$ 11.142  Millions
Moderna Inc   1.07 $ 10,799.000  Millions$ 10,124.000  Millions
Aytu Biopharma inc   1.04 $ 116.229  Millions$ 111.500  Millions
Axcella Health Inc   0.94 $ 33.260  Millions$ 35.561  Millions
Sangamo Therapeutics Inc   0.90 $ 366.382  Millions$ 406.016  Millions
Emergent Biosolutions Inc   0.88 $ 1,344.800  Millions$ 1,522.700  Millions
Regenxbio Inc   0.73 $ 338.981  Millions$ 461.414  Millions
Merus N v   0.73 $ 150.158  Millions$ 205.769  Millions
Armata Pharmaceuticals Inc   0.72 $ 17.187  Millions$ 23.755  Millions
Taysha Gene Therapies Inc   0.72 $ 100.648  Millions$ 140.394  Millions
Genocea Biosciences Inc   0.72 $ 27.089  Millions$ 37.829  Millions
Cytrx Corporation  0.71 $ 7.085  Millions$ 9.952  Millions
Pluristem Therapeutics Inc  0.71 $ 34.746  Millions$ 48.907  Millions
Chromadex Corporation  0.71 $ 25.003  Millions$ 35.449  Millions
Champions Oncology Inc   0.70 $ 5.638  Millions$ 8.071  Millions
Windtree Therapeutics Inc  0.68 $ 34.368  Millions$ 50.179  Millions
Eloxx Pharmaceuticals Inc   0.68 $ 22.385  Millions$ 32.998  Millions
Curis Inc   0.67 $ 68.520  Millions$ 102.909  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OCC's Profile

Stock Price

OCC's Financials

Business Description

Fundamentals

Charts & Quotes

OCC's News

Suppliers

OCC's Competitors

Customers & Markets

Economic Indicators

OCC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071